- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Guidelines and Recommendations for Palliative Care
During this Insights interview with Genevieve Kumapley, PharmD, BCOP, on the Use of Oral Oncolytics in Palliative Care, part of the Oncology Stakeholders Summit, Spring 2015 series, Dr Kumapley discusses current guidelines for the delivery of palliative care and describes gaps in care.
Recent guidelines by the National Comprehensive Cancer Network and the American Society of Clinical Oncology recommend a multidisciplinary management approach when caring for patients, says Dr Kumapley, an oncology clinical pharmacy specialist for Saint Peter’s Healthcare System. Employing a multidisciplinary management approach is essential to providing the best quality of care, she adds, as such an approach enables providers to consider spiritual, psychosocial, and cultural issues that may be important to patients.
However, Dr Kumapley suggests that certain gaps in care need to be addressed; for instance, most palliative care is provided in the hospital, even though doing so earlier in a patient’s diagnosis and in the outpatient setting is equally important. Outpatient facilities are often where patients first receive their cancer diagnosis, says Dr Kumapley. Providing palliative care in the outpatient setting also increases reimbursement opportunities for cancer care teams, she suggests.
Nomogram Predicts Overall Survival in Patients With Ovarian Cancer, Liver Metastases
January 9th 2025Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in stability and accuracy.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
January 9th 2025Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in pivotal clinical trials among patients with different types of multiple sclerosis (MS).
Read More
New Research Links Gender, Racial Microaggressions to Higher Postpartum Blood Pressure
January 9th 2025Acts of discrimination, including subtle microaggressions, during pregnancy and childbirth contribute to higher maternal mortality rates, especially among Black women, and are linked to increased postpartum blood pressure, highlighting the need for improved health care interventions and racial equity in maternity care.
Read More
